Share on StockTwits

Vital Therapies (NYSE:VTL) Director Muneer A. Satter purchased 14,500 shares of the stock on the open market in a transaction that occurred on Tuesday, June 3rd. The shares were purchased at an average cost of $13.16 per share, with a total value of $190,820.00. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Several analysts have recently commented on the stock. Analysts at Bank of America initiated coverage on shares of Vital Therapies in a research note on Monday, May 12th. They set a “buy” rating on the stock. Separately, analysts at Canaccord Genuity initiated coverage on shares of Vital Therapies in a research note on Monday, May 12th. They set a “buy” rating and a $20.00 price target on the stock. Finally, analysts at William Blair initiated coverage on shares of Vital Therapies in a research note on Monday, May 12th. They set an “outperform” rating and a $28.00 price target on the stock.

Shares of Vital Therapies (NYSE:VTL) traded up 0.29% on Wednesday, hitting $14.01. 21,177 shares of the company’s stock traded hands. Vital Therapies has a 1-year low of $10.66 and a 1-year high of $14.50. The stock has a 50-day moving average of $12.37 and a 200-day moving average of $12.37. The company’s market cap is $295.8 million.

Vital Therapies (NYSE:VTL) last posted its quarterly earnings results on Tuesday, June 3rd. The company reported ($24.49) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.54) by $23.95. On average, analysts predict that Vital Therapies will post $-2.47 earnings per share for the current fiscal year.

Vital Therapies, Inc is a biotherapeutic company. The Company focused on developing a cell-based therapy targeting the treatment of all forms of acute liver failure.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.